I'm a member
You will be redirected to myBlue. Would you like to continue?
Please wait while you are redirected.
Printer Friendly Version
An alternative to needles and syringes for insulin administration are needle-free insulin injection systems or jet injectors. These devices eject a narrow stream of insulin through a fine-holed nozzle under high pressure and at high speed so that the insulin penetrates the skin and is dispersed subcutaneously.
The goals of injecting insulin with needle-free insulin injection systems, or jet injectors, in the treatment of diabetes are to prevent long-term complications by ensuring optimal glycemic control and to encourage compliance with intensive therapy in patients with needle phobias or who experience pain upon injection.
Needle-Free Insulin Injection Systems are considered investigational.
Investigative service is defined as the use of any treatment procedure, facility, equipment, drug, device, or supply not yet recognized by certifying boards and/or approving or licensing agencies or published peer review criteria as standard, effective medical practice for the treatment of the condition being treated and as such therefore is not considered medically necessary.
The coverage guidelines outlined in the Medical Policy Manual should not be used in lieu of the Member's specific benefit plan language.
POLICY HISTORY5/2001: Approved by Medical Policy Advisory Committee (MPAC)
7/13/2001: Code Reference section completed, HCPCS A4210 added
2/13/2002: Investigational definition added
5/2/2002: Type of Service and Place of Service deleted
8/15/2005: Code Reference section reviewed, no changes
10/23/2006: Policy reviewed, no changes
Hayes Medical Technology Directory
CODE REFERENCEThis may not be a comprehensive list of procedure codes applicable to this policy.